Alnylam Pharmaceuticals has filed a motion in Delaware federal court seeking to dismiss a lawsuit brought by its former collaborator, Acuitas Therapeutics Inc. The suit by Acuitas aims to add its scientists as inventors on patents that Alnylam claims are being infringed by the COVID-19 vaccines produced by Pfizer and Moderna. This legal maneuvering highlights the ongoing patent disputes surrounding COVID-19 vaccine technology, reflecting broader tensions in the biopharmaceutical industry. For more details on the case, read the full article here.